Effectiveness of Inhaled COVID-19 Vaccines to Be Studied
MONDAY, Sept. 14, 2020 -- A study to assess the effectiveness of two experimental COVID-19 vaccines when they are inhaled, rather than injected, has been announced by researchers.
The trial will test the responses of 30 people, ages 18 to 55 years, when they inhale vaccine droplets in their mouths, which would directly target their respiratory systems, explained the scientists at Imperial College London and Oxford University in the United Kingdom, the Associated Press reported.
"We have evidence that delivering influenza vaccines via a nasal spray can protect people against flu as well as help to reduce the transmission of the disease," and this might also be the case with the new coronavirus, research leader Chris Chiu, Ph.D., of Imperial College London, said in a statement.
Clinical trials of the vaccines' effectiveness when injected are already underway. "It is critical we explore whether targeting the airways directly can provide an effective response compared to a vaccine injected into muscle," according to Chiu, the AP reported.
© 2020 HealthDay. All rights reserved.
Posted: September 2020
Further Support and Information on COVID-19
Read this next
FRIDAY, Sept. 18, 2020 -- More than half of hospitalized pregnant women with COVID-19 are asymptomatic at admission, while pregnant women hospitalized for COVID-19-related illness have...
FRIDAY, Sept. 18, 2020 -- The proportion of inpatients with COVID-19 who wear eyeglasses for extended daily periods is lower than in the general population, according to a study published...
FRIDAY, Sept. 18, 2020 -- Older adults are feeling more isolated during the COVID-19 pandemic, according to a report published online Sept. 14 based on the results of the University...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.